Gaviscon maker is accused of rigging the marketBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1121 (Published 24 February 2010) Cite this as: BMJ 2010;340:c1121
- Zosia Kmietowicz
The household products company Reckitt Benckiser UK is being investigated by the Office of Fair Trading (OFT) over whether it manipulated the market for its heartburn drug Gaviscon.
The OFT alleges that the company sought to restrict competition to its Gaviscon brand of compound alginate preparations when it withdrew and delisted its Gaviscon Original Liquid from the NHS prescription channel in 2005 and introduced Gaviscon Advance, which was protected by …
Log in using your username and password
Log in through your institution
Sign up for a free trial